Racial/Ethnic Differences in the Quality of Substance Abuse Treatment

药物滥用治疗质量的种族/民族差异

• 批准号: 7675054
• 负责人: Andrea Acevedo
• 金额: $ 2.65万
• 依托单位: BRANDEIS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7675054
• 关键词: Accident and Emergency department; Accounting; Admission activity; Adopted; Alcohol or Other Drugs use; Caring; Characteristics; Client; Communities; Data; Disease; Drug Metabolic Detoxication; Ethnic Origin; Ethnic group; Event; Funding; Goals; Individual; Institute of Medicine (U.S.); Institution; Lead; Link; Massachusetts; Measures; Outcome; Outpatients; Patients; Performance; Phase; Psyche structure; Quality Indicator; Quality of Care; Race; Reporting; Research; Services; Substance Use Disorder; Substance abuse problem; Testing; Time; Treatment outcome; Visit; Washington; alcohol and other drug; base; health care quality; improved; indexing; programs; racial and ethnic; racial and ethnic disparities; racial/ethnic difference

DESCRIPTION (provided by applicant): The treatment for alcohol and other drug disorders has been shown to be effective, yet previous research suggests that the quality of treatment received may differ based on client's race/ethnicity. The goal of this study is to increase our understanding of racial/ethnic differences in the quality of treatment for substance use disorders. Specifically, this study aims to: 1) Examine whether racial/ethnic differences in quality indicators of substance abuse treatment exist. The widely adopted quality indicator measures for outpatient substance abuse treatment, the Washington Circle performance measures of treatment initiation and engagement, will be used to assess treatment quality. 2) Test whether client-, facility-, and community-level predictors of treatment initiation and engagement differ by clients' race/ethnicity; 3) Evaluate whether race/ethnicity moderates the relationship between treatment engagement and subsequent treatment outcomes, specifically emergency department visits and detoxification admissions. This study will use administrative data from Massachusetts' publicly-funded outpatient substance abuse treatment services in 2006. The data will be linked with data on emergency department visits across the state. To accomplish the first two aims, multilevel regressions will be employed to account for within-facility correlations of clients' initiation and engagement status. To accomplish the third aim, survival (time-to-event) analyses will be employed. The outcomes will be measured in the year following the index visit to outpatient treatment, controlling for client-, facility-, and community-level factors. Furthering our understanding on racial/ethnic disparities in treatment quality could offer ways for states and programs to improve treatment quality for clients from diverse backgrounds and lead to better treatment outcomes.

描述（由申请人提供）：对酒精和其他药物障碍的治疗已被证明是有效的，但以前的研究表明，所接受的治疗质量可能因客户的种族/民族而异。本研究的目的是增加我们对物质使用障碍治疗质量的种族/民族差异的理解。具体而言，本研究旨在：1)检验药物滥用治疗质量指标是否存在种族差异。广泛采用的门诊药物滥用治疗质量指标措施，即华盛顿圈治疗开始和参与的绩效措施，将用于评估治疗质量。2)测试客户、机构和社区层面的治疗开始和参与的预测因素是否因客户的种族/民族而不同；3)评估种族/民族是否调节治疗参与和后续治疗结果之间的关系，特别是急诊就诊和戒毒入院。这项研究将使用2006年马萨诸塞州公共资助的门诊药物滥用治疗服务的行政数据。这些数据将与全州急诊室就诊的数据联系起来。为了实现前两个目标，将采用多层次回归来解释客户启动和参与状态的设施内相关性。为了实现第三个目标，将使用生存（时间到事件）分析。结果将在对门诊治疗进行指数访问后的一年内进行测量，控制客户，设施和社区水平的因素。加深我们对治疗质量中种族/民族差异的理解可以为各州和项目提供方法，以提高来自不同背景的客户的治疗质量，并带来更好的治疗效果。